TEVOGEN BIO HOLDINGS INC. - COMMON STOCK
1.4700
07-二月-25 16:45:00
15 分钟延时
股票
+0.0500
+3.52%
今日范围
1.3900 - 1.5000
ISIN
N/A
来源
NASDAQ
-
11 4月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
03 4月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
28 3月 2024 08:05:00 条件 Nasdaq GlobeNewswire